About
Our Medicine
Science
& Pipeline
Patients
Healthcare
Professionals
Investors
Company Overview
News Releases
Events & Presentations
Stock Information
Analyst Coverage
Governance
SEC Filings
Investor FAQs
Careers
About
Our Medicine
Science
& Pipeline
Patients
Healthcare
Professionals
Investors
Company Overview
News Releases
Events & Presentations
Stock Information
Analyst Coverage
Governance
SEC Filings
Investor FAQs
Careers
Rare
Resolve
.
Driving progress for people living with rare immune disorders
ABBEY
Living with Chronic Neutropenia
recent news
X4 Pharmaceuticals Announces Pricing of $135 Million Underwritten Public Offering
October 24, 2025
X4 Pharmaceuticals Announces Proposed Underwritten Public Offering
October 23, 2025
X4 Pharmaceuticals Announces Restructuring of Business Operations Designed to Drive Long-Term Value Creation
September 17, 2025
More News
© Copyright 2025 X4 Pharmaceuticals. All Rights Reserved.
Terms of Use
|
Privacy
|
Compliance and Ethics
